Petra Huehnchen

Anna Louisa Karsch Str. 2
Berlin, BE 10178, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Symptom-guided approach to central nervous system complications in allogeneic hematopoietic cell transplant recipients: Best practice recommendations from the EBMT Practice Harmonisation and Guidelines committee.

Symptom-guided approach to central nervous system complications in allogeneic hematopoietic cell transplant recipients: Best practice recommendations from the EBMT Practice Harmonisation and Guidelines committee.

Journal: Bone marrow transplantation

Published: March 06, 2026

Central nervous system complications after allogeneic haematopoietic cell transplantation: best practice recommendations from the EBMT practice harmonisation and guidelines committee on epidemiology, outcome and neuroimaging.

Central nervous system complications after allogeneic haematopoietic cell transplantation: best practice recommendations from the EBMT practice harmonisation and guidelines committee on epidemiology, outcome and neuroimaging.

Journal: Bone marrow transplantation

Published: March 06, 2026

Virus-Specific T Cells and Response to Checkpoint Inhibitors in Progressive Multifocal Leukoencephalopathy.

Virus-Specific T Cells and Response to Checkpoint Inhibitors in Progressive Multifocal Leukoencephalopathy.

Journal: JAMA neurology

Published: January 20, 2026

The Berlin-Hannover ICANS severity assessment-a novel bedside test to evaluate CAR T-cell-associated neurotoxicity.

The Berlin-Hannover ICANS severity assessment-a novel bedside test to evaluate CAR T-cell-associated neurotoxicity.

Journal: Frontiers in neurology

Published: October 16, 2025

Clonally expanded effector CD4+ cytotoxic T lymphocytes are associated with severe neurological adverse events after immune checkpoint inhibitor therapy.

Clonally expanded effector CD4+ cytotoxic T lymphocytes are associated with severe neurological adverse events after immune checkpoint inhibitor therapy.

Journal: Journal for immunotherapy of cancer

Published: September 14, 2025

HLA-A01:01-B08:01-C*07:01 is linked to early-onset immune checkpoint inhibitor-induced myositis and myocarditis.

HLA-A01:01-B08:01-C*07:01 is linked to early-onset immune checkpoint inhibitor-induced myositis and myocarditis.

Journal: Journal for immunotherapy of cancer

Published: September 01, 2025

Time‑resolved multi-omic analysis of paclitaxel exposure in human iPSC‑derived sensory neurons unveils mechanisms of chemotherapy‑induced peripheral neuropathy.

Time‑resolved multi-omic analysis of paclitaxel exposure in human iPSC‑derived sensory neurons unveils mechanisms of chemotherapy‑induced peripheral neuropathy.

Journal: Cell death & disease

Published: July 22, 2025

c-Jun inhibition mitigates chemotherapy-induced neurotoxicity in iPSC-derived sensory neurons.

c-Jun inhibition mitigates chemotherapy-induced neurotoxicity in iPSC-derived sensory neurons.

Journal: Cell death discovery

Published: May 02, 2025

Complement activation profiles in patients with immune checkpoint inhibitor-associated neuromuscular immune-related adverse events.

Complement activation profiles in patients with immune checkpoint inhibitor-associated neuromuscular immune-related adverse events.

Journal: Journal of neurology

Published: March 29, 2025

The expanding clinical utility of blood neurofilament light chain (bNfL): a multi-disciplinary diagnostic tool.

The expanding clinical utility of blood neurofilament light chain (bNfL): a multi-disciplinary diagnostic tool.

Journal: Journal of the neurological sciences

Published: March 25, 2025

Generation of ten human induced pluripotent stem cell lines (hiPSCs) from patients with and without Chemotherapy-Induced Peripheral Neuropathy (CIPN) and Post Chemotherapy Cognitive Impairment (PCCI).

Generation of ten human induced pluripotent stem cell lines (hiPSCs) from patients with and without Chemotherapy-Induced Peripheral Neuropathy (CIPN) and Post Chemotherapy Cognitive Impairment (PCCI).

Journal: Stem cell research

Published: December 06, 2024

Results of the preclinical multicenter randomized controlled paclitaxel-induced neuropathy prevention replication study (PINPRICS).

Results of the preclinical multicenter randomized controlled paclitaxel-induced neuropathy prevention replication study (PINPRICS).

Journal: BMC research notes

Published: August 08, 2024

Showing 1-12 of 42

Last Updated: 09/26/2026